Average Co-Inventor Count = 5.19
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (7 from 212 patents)
2. Merck Frosst Canada & Co. (4 from 76 patents)
3. Merck + Co., Inc. (2 from 4,770 patents)
4. Actelion Pharmaceuticals Ltd (1 from 217 patents)
14 patents:
1. 7968720 - Secondary amines as renin inhibitors
2. 7687524 - Cathepsin cysteine protease inhibitors
3. 7279478 - Cathepsin cysteine protease inhibitors
4. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
5. 6410583 - Cyclopentanoindoles, compositions containing such compounds and methods of treatment
6. 5424320 - Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
7. 5360815 - Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis
8. 5281720 - Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene
9. 5227399 - Pyranylphenyl naphthalene lactones as inhibitors of leukotriene
10. 5202321 - Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
11. 5087638 - Benzofuran derivatives
12. 4863958 - Benzofuran derivatives useful as inhibitors of mammalian leukotriene
13. 4728735 - 10,11-dihydro-dibenzo-[b,f][1,4]-thiazepin derivatives
14. 4334077 - Stereospecific sulfoxidation of dibenzo thiepins